TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 151 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 21.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $552,520 | +36.4% | 15,200 | -24.0% | 0.03% | +7.4% |
| Q4 2023 | $405,000 | +85.5% | 20,000 | +15.2% | 0.03% | +107.7% |
| Q1 2023 | $218,278 | -19.8% | 17,365 | -6.5% | 0.01% | -7.1% |
| Q4 2022 | $272,163 | -5.5% | 18,565 | +10.4% | 0.01% | +40.0% |
| Q3 2022 | $288,000 | +3.6% | 16,821 | -11.7% | 0.01% | +25.0% |
| Q2 2022 | $278,000 | – | 19,049 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,254,797 | $61,285,382 | 6.24% |
| Ikarian Capital, LLC | 800,277 | $21,751,529 | 3.79% |
| TFG Asset Management GP Ltd | 500,000 | $13,590,000 | 3.39% |
| Paradigm Biocapital Advisors LP | 2,435,416 | $66,194,607 | 2.53% |
| Frazier Life Sciences Management, L.P. | 1,587,527 | $43,148,984 | 2.02% |
| Ghost Tree Capital, LLC | 235,000 | $6,387,300 | 2.00% |
| COWEN AND COMPANY, LLC | 2,197,385 | $59,724,924 | 1.64% |
| TCG Crossover Management, LLC | 556,317 | $15,120,696 | 1.58% |
| Sands Capital Ventures, LLC | 170,000 | $4,620,600 | 1.55% |
| BOONE CAPITAL MANAGEMENT LLC | 216,047 | $5,872,157 | 1.53% |